Endothelin Receptor Antagonists for Pulmonary Hypertension in Adult Patients With Sickle Cell Disease

British Journal of Haematology - United Kingdom
doi 10.1111/j.1365-2141.2009.07906.x
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

Pulmonary Hypertension in Sickle Cell Disease

New England Journal of Medicine
Medicine
2011English

Sildenafil Therapy in Patients With Sickle Cell Disease and Pulmonary Hypertension

British Journal of Haematology
Hematology
2005English

Clinical Profiling of Sickle Cell Disease Patients With Respect to Pulmonary Hypertension

International Journal of Scientific Reports
2017English

Severe Pulmonary Hypertension in an Adolescent With Sickle Cell Disease

American Journal of Hematology
Hematology
2007English

Is There a Role for Endothelin-1 Receptor Antagonists in the Treatment of Lung Fibrosis Associated With Pulmonary Hypertension?

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2018English

Relative Systemic Hypertension in Patients With Sickle Cell Disease Is Associated With Risk of Pulmonary Hypertension and Renal Insufficiency

American Journal of Hematology
Hematology
2007English

Survival of Japanese Patients With Pulmonary Arterial Hypertension After the Introduction of Endothelin Receptor Antagonists and/or Phosphodiesterase Type-5 Inhibitors

Internal Medicine
Internal MedicineMedicine
2012English

Coagulation Activation and Inflammation in Sickle Cell Disease-Associated Pulmonary Hypertension

Haematologica
Hematology
2008English

A Clinical Risk Score for Pulmonary Artery Thrombosis During Acute Chest Syndrome in Adult Patients With Sickle Cell Disease

British Journal of Haematology
Hematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy